Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1989-02-13 (37 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CANY-BARVILLE (76450), Seine-Maritime
PHARMACIE JUMEAU : revenue, balance sheet and financial ratios
PHARMACIE JUMEAU is a French company
founded 37 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CANY-BARVILLE (76450),
this company of category PME
shows in 2024 a revenue of 3.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JUMEAU (SIREN 350205407)
Indicator
2025
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
3 789 230 €
3 659 776 €
3 464 742 €
2 991 992 €
2 708 285 €
2 536 083 €
2 577 917 €
2 635 027 €
Net income
182 520 €
232 546 €
238 309 €
257 220 €
273 153 €
257 560 €
236 980 €
254 446 €
258 039 €
EBITDA
N/C
302 131 €
317 549 €
329 058 €
363 783 €
342 380 €
332 560 €
366 360 €
356 795 €
Net margin
N/C
6.1%
6.5%
7.4%
9.1%
9.5%
9.3%
9.9%
9.8%
Revenue and income statement
In 2025, PHARMACIE JUMEAU generates positive net income of 183 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 258 k€ -> 183 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
182 520 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
26.585%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.811%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Debt ratio
54.595
0.0
28.035
14.495
7.56
29.572
33.281
23.884
26.585
Financial autonomy
57.062
66.231
70.284
77.729
81.899
68.774
66.405
71.159
68.811
Repayment capacity
2.114
0.0
1.398
0.734
0.405
1.72
2.034
1.453
None
Cash flow / Revenue
9.331%
10.158%
9.511%
9.768%
9.311%
7.226%
6.631%
6.281%
None%
Sector positioning
Debt ratio
26.592025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE JUMEAU (26.59) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.81%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE JUMEAU (68.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
1.45 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good
In 2024, the repayment capacity of PHARMACIE JUMEAU (1.45) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 372.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
372.947
Liquidity indicators evolution PHARMACIE JUMEAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Liquidity ratio
310.426
352.964
0.0
345.934
0.0
458.61
458.135
407.394
372.947
Interest coverage
4.95
3.248
2.264
0.998
0.524
1.476
5.984
5.582
None
Sector positioning
Liquidity ratio
372.952025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE JUMEAU (372.95) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
5.58x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Good-7 pts over 2 years
In 2024, the interest coverage of PHARMACIE JUMEAU (5.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JUMEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
2025
Operating WCR
183 740 €
190 250 €
-64 924 €
144 731 €
-82 669 €
196 278 €
223 759 €
289 573 €
0 €
Inventory turnover (days)
23
0
0
21
0
19
21
20
0
Customer payment term (days)
11
10
0
7
0
7
7
12
0
Supplier payment term (days)
20
19
22
20
22
21
22
20
0
Positioning of PHARMACIE JUMEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE JUMEAU is estimated at
2 899 351 €
(range 1 967 513€ - 4 549 482€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1967k€2899k€4549k€
2 899 351 €Range: 1 967 513€ - 4 549 482€
NAF 5 année 2025
Valuation method used
Net Income Multiple
182 520 €
×
15.9x
=2 899 352 €
Range: 1 967 514€ - 4 549 482€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JUMEAU with other companies in the same sector:
The revenue of PHARMACIE JUMEAU in 2024 is 3.8 M€.
Is PHARMACIE JUMEAU profitable?
Yes, PHARMACIE JUMEAU generated a net profit of 183 k€ in 2025.
Where is the headquarters of PHARMACIE JUMEAU ?
The headquarters of PHARMACIE JUMEAU is located in CANY-BARVILLE (76450), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE JUMEAU ?
The tax return of PHARMACIE JUMEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JUMEAU operate?
PHARMACIE JUMEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart